Live Breaking News & Updates on Breethe Oxy

Stay updated with breaking news from Breethe oxy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Abiomed stock soars on Q3 results, Johnson & Johnson to acquire

Abiomed shares soared today on third-quarter results and the news of its acquisition by Johnson & Johnson. ....

Massachusetts , United-states , Breethe-oxy , Michaelr-minogue , Abiomed , Johnson , Low-profile-sheath ,

Here's the Surprising Coronavirus Stock You'll Really Want to Own


Author Bio
Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories. Prior to joining The Fool as a contract writer focused on healthcare and consumer goods, Adria covered the stock market for Bloomberg News in Paris. When she’s not analyzing companies, she can be found writing fiction or trying to speak French as well as her 9-year-old daughter.
Follow @adria in paris
When most of us think of coronavirus stocks, we think of vaccine makers or companies developing therapeutics. We probably don t think of medical device players specializing in heart pumps. ....

Breethe-oxy , Abiomed , Drug-administration , Emergency-use-authorization , அவசரம்-பயன்பாடு-அங்கீகாரம் ,

Will Recovering COVID-19 Patients Soon Be Walking Around on ECMO?


email article
A compact extracorporeal membrane oxygenation (ECMO) system built for mobility was greeted with enthusiasm at the Society of Thoracic Surgeons (STS) virtual meeting.
The Breethe Oxy-1 machine was designed for prolonged use in critically ill patients, providing veno-venous or veno-arterial support in either bedside or portable modes. Another notable feature of Breethe is the divided gas path design that separates oxygenation from carbon dioxide removal, according to Bartley Griffith, MD, of University of Maryland School of Medicine in Baltimore.
At the STS meeting, the ambulatory ECMO system informally won the Shark Tank session with 42% of audience votes.
Abiomed had acquired the device in May 2020. In October, the company received FDA 510(k) clearance for the Breethe to be used for ECMO in cardiogenic shock or respiratory failure for a maximum of 6 hours at a time. ....

Texas-medical-center , Texas , United-states , Houston , Bartley-griffith , Breethe-oxy , William-cohn , Abiomed , University-of-maryland-school-medicine , Society-of-thoracic-surgeons , Johnson , Thoracic-surgeons